OS Therapies Inc. Form 8-K Summary
Business Context and Reporting Period
Company: OS Therapies Inc.
Reporting Date: August 22, 2024
Business Description: An ADC and immunotherapy research and clinical-stage biopharmaceutical company.
Listing: Common Stock (Symbol: OSTX) trades on the NYSE American under CUSIP 68764Y207.
Financial Metrics
This filing is a Current Report (Form 8-K) regarding a corporate clarification event. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metric.
Material Changes
No material financial changes or operational updates are reported in this document. The filing serves solely to clarify the correct CUSIP number for the company's common stock to market participants and brokerage firms.
Guidance, Outlook, and Risks
The filing contains no management guidance, future outlook, risk factors, contingencies, or discussion of unusual items. The primary purpose is to correct market data regarding the stock's CUSIP identifier.
Key Facts for Investor Verification
- Verify that trading systems and brokerage accounts reflect the correct CUSIP: 68764Y207 for OSTX.
- Confirm the stock is listed on the NYSE American exchange.
- Note that this filing does not include financial performance data; refer to recent 10-Q or 10-K filings for financial metrics.